DHA 40mg / PPQ 320mg, blister of 6 tab., 24-34 kg
STD
DORADHAP3T1
Valid Article
Account code:
60000
HS Code:
300460
Last Updated on:
02/05/2024, 22:05:30
Former
Code(s):
DORADHAP03-
6.5.3.1 - For curative treatment
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BF05
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
DIHYDROARTEMISININ (DHA)/PIPERAQUINE (PPQ)
Therapeutic Action
Fixed-dose combination (FDC) of two antimalarials
Indications
First or second-line treatment of uncomplicated malaria, depending on the context
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Blister presentation for 3 days treatment.
5 different presentations for 5 categories of weight:
- infants / small children 5-12 kg: blister of 3 tab. (20/160 mg)
- children 13-23 kg: blister of 3 tab. (40/320 mg)
- adolescents 24-34 kg: blister of 6 tab. (40/320 mg)
- adults 35-74 kg: blister of 9 tab. (40/320 mg)
- tall adults 75-100 kg: blister of 12 tab. (40/320 mg)
Presentations must be ordered for all 5 weight categories.
The quantity to be ordered is calculated per blister (= one treatment), not per tablet.
Storage
- Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
- Shelf life: maximum 24 months